Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens

Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens

Infections by Gram-negative multi-drug resistant (MDR) bacterial species are difficult to treat using available antibiotics. Overuse of carbapenems has contributed to widespread resistance to these antibiotics; as a result, carbapenem-resistant Enterobacterales (CRE), A. baumannii (CRAB), and P. aer...

Full description

Bibliographic Details
Main Authors: Flora Cruz-López, Adrian Martínez-Meléndez, Rayo Morfin-Otero, Eduardo Rodriguez-Noriega, Héctor J. Maldonado-Garza, Elvira Garza-González
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
carbapenemase
drug resistance
new antibiotics
acinetobacter
gram negatives
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.884365/full

Internet

https://www.frontiersin.org/articles/10.3389/fcimb.2022.884365/full

Similar Items